 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 GLOBE NEWSWIRE -- Sutro Biopharma, Inc. Sutro or the Company NASDAQ: STRO, a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates ADCs, today announced that Bill Newell, Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 11:15 a.m. PT 2:15 p.m. ET in San Francisco, CA. 